← Leaderboards
Jane Azizkhan-Clifford
Roswell Park Cancer Institute Corp
$1,771,207
Attributed
$1,771,207
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,771,207 · 2
By mechanism
R01$1,771,207 · 2
Top collaborators
No co-investigators on record.
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Heinz Baumann$4,783,902
- Veena Prahlad$5,516,697
- Kenneth W Gross$7,053,357
- Terry A Beerman$2,995,116
- Nicoletta Sacchi$1,682,554
Others in their field
Top investigators on “Cell Cycle”
- Bruce W Stillman · Cold Spring Harbor Laboratory$87,228,479
- Gregory D Peterson · University Of Tennessee Knoxville$84,527,696
- Nevan J Krogan · University Of California, San Francisco$83,822,021
- Mary M Horowitz · Medical College Of Wisconsin$76,714,344
- Frank Patrick McCormick · University Of California San Francisco$75,259,666
- David Heimbrook · Leidos Biomedical Research, Inc.$68,555,131
Research focus
Cell CycleTissue /Cell CultureTranscription FactorPhosphorylationImmunoprecipitationIntermolecular InteractionDihydrofolate ReductaseGenetic Promoter ElementGenetic TranscriptionPhosphoproteinsVirus Infection MechanismEnzyme ActivityPolymerase Chain ReactionProtein KinaseCytomegalovirusCell Free SystemTransfectionGene Mutation
Grant awards (7)
E2F/Spl Synergy in Cell Cycle Regulated Transcription$271,800
R01 · FY2004 · CA
E2F/Spl Synergy in Cell Cycle Regulated Transcription$271,800
R01 · FY2003 · CA
E2F/Spl Synergy in Cell Cycle Regulated Transcription$271,800
R01 · FY2002 · CA
E2F/Spl Synergy in Cell Cycle Regulated Transcription$273,600
R01 · FY2001 · CA
HCMV, CELL GROWTH STATE, AND TRANSCRIPTION FACTOR E2F$219,071
R01 · FY2001 · CA
E2F/Spl Synergy in Cell Cycle Regulated Transcription$271,800
R01 · FY2000 · CA
HCMV, CELL GROWTH STATE, AND TRANSCRIPTION FACTOR E2F$191,336
R01 · FY2000 · CA